181 related articles for article (PubMed ID: 38433526)
1. ILT4 facilitates angiogenesis in non-small cell lung cancer.
Wang S; Wang J; Gong W; Zhang F; Chen X; Xu H; Han Y; Fu X; Wang L; Li J; Gao A; Sun Y
Cancer Sci; 2024 May; 115(5):1459-1475. PubMed ID: 38433526
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer.
Zhang P; Guo X; Li J; Yu S; Wang L; Jiang G; Yang D; Wei Z; Zhang N; Liu J; Sun Y
Oncotarget; 2015 May; 6(15):13550-63. PubMed ID: 25948790
[TBL] [Abstract][Full Text] [Related]
3. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
4. ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer.
Li J; Gao A; Zhang F; Wang S; Wang J; Wang J; Han S; Yang Z; Chen X; Fang Y; Jiang G; Sun Y
Cancer Lett; 2021 Mar; 501():263-276. PubMed ID: 33152402
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of immunoglobulin-like transcript 4 and angiopoietin-like proteins in human non-small cell lung cancer.
Wang L; Geng T; Guo X; Liu J; Zhang P; Yang D; Li J; Yu S; Sun Y
Mol Med Rep; 2015 Apr; 11(4):2789-96. PubMed ID: 25482926
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived Immunoglobulin-like transcript 4 facilitates angiogenesis of colorectal cancer.
Liu J; Zhang F; He J; Wang S; Wang L; Li J; Shi W; Han Y; Gao A; Sun Y
Am J Cancer Res; 2023; 13(2):419-435. PubMed ID: 36895964
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling.
Zhang Y; Zhao J; Qiu L; Zhang P; Li J; Yang D; Wei X; Han Y; Nie S; Sun Y
Tumour Biol; 2016 Aug; 37(8):11187-98. PubMed ID: 26939901
[TBL] [Abstract][Full Text] [Related]
8. The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma.
García M; Palma MB; Verine J; Miriuka S; Inda AM; Errecalde AL; Desgrandchamps F; Carosella ED; Tronik-Le Roux D
BMC Cancer; 2020 Jul; 20(1):624. PubMed ID: 32620162
[TBL] [Abstract][Full Text] [Related]
9. ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer.
Zhang P; Yu S; Li H; Liu C; Li J; Lin W; Gao A; Wang L; Gao W; Sun Y
FEBS Lett; 2015 Aug; 589(17):2248-56. PubMed ID: 26149216
[TBL] [Abstract][Full Text] [Related]
10. Targeting angiogenesis in squamous non-small cell lung cancer.
Piperdi B; Merla A; Perez-Soler R
Drugs; 2014 Mar; 74(4):403-13. PubMed ID: 24578213
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways.
Yao M; Zhang W; Zhang Q; Xing L; Xu A; Liu Q; Cui B
Lung; 2011 Dec; 189(6):453-60. PubMed ID: 21959954
[TBL] [Abstract][Full Text] [Related]
12. PVT1 Promotes Angiogenesis by Regulating miR-29c/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway in Non-Small-Cell Lung Cancer (NSCLC).
Mao Z; Xu B; He L; Zhang G
Med Sci Monit; 2019 Jul; 25():5418-5425. PubMed ID: 31326971
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity.
Gao A; Liu X; Lin W; Wang J; Wang S; Si F; Huang L; Zhao Y; Sun Y; Peng G
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33653799
[TBL] [Abstract][Full Text] [Related]
14. Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility.
Rapp J; Kiss E; Meggyes M; Szabo-Meleg E; Feller D; Smuk G; Laszlo T; Sarosi V; Molnar TF; Kvell K; Pongracz JE
BMC Cancer; 2016 Nov; 16(1):915. PubMed ID: 27876017
[TBL] [Abstract][Full Text] [Related]
15. Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer.
Zhang X; Wang Y; Fan J; Chen W; Luan J; Mei X; Wang S; Li Y; Ye L; Li S; Tian W; Yin K; Ju D
J Immunother Cancer; 2019 Dec; 7(1):346. PubMed ID: 31829270
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.
Yu W; Chen L; Yang YQ; Falck JR; Guo AM; Li Y; Yang J
Cancer Chemother Pharmacol; 2011 Sep; 68(3):619-29. PubMed ID: 21120482
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
[TBL] [Abstract][Full Text] [Related]
18. Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer.
Deacon K; Onion D; Kumari R; Watson SA; Knox AJ
J Biol Chem; 2012 Nov; 287(47):39967-81. PubMed ID: 22992725
[TBL] [Abstract][Full Text] [Related]
19. Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer.
Chatterjee S; Heukamp LC; Siobal M; Schöttle J; Wieczorek C; Peifer M; Frasca D; Koker M; König K; Meder L; Rauh D; Buettner R; Wolf J; Brekken RA; Neumaier B; Christofori G; Thomas RK; Ullrich RT
J Clin Invest; 2013 Apr; 123(4):1732-40. PubMed ID: 23454747
[TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.
Qi L; Zhu F; Li SH; Si LB; Hu LK; Tian H
PLoS One; 2014; 9(8):e106032. PubMed ID: 25162518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
